跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CALQUENCE 100 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CALQUENCE 100 MG CAPSULAS DURAS
Approved
STANDARD
CALQUENCE 100 MG CAPSULAS DURAS
Astrazeneca Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 17, 2020
Approval ID
ac3aab94453cb073
Company
Astrazeneca Ab
Type
Standard
Approval Details
Approval Id
ac3aab94453cb073
Drug Cima Aemps Name
CALQUENCE 100 MG CAPSULAS DURAS
Register Number
1201479002
Holder Company Name
Astrazeneca Ab
Marketing Company Name
Astrazeneca Farmaceutica Spain S.A.
Holder Company Detail Path
/organization/astrazeneca-ab
Authorization Date
2020-11-17
Dosage Form
CÁPSULA DURA
Dose
100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Astrazeneca Ab
Company Detail Path
/organization/astrazeneca-ab
Company Information
Pharmaceutical Company Name
AstraZeneca AB
Name En
AstraZeneca AB
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE RAIMUNDO FERNANDEZ VILLAVERDE 63
Website
http://www.astrazeneca.se
Active Ingredients
ACALABRUTINIB
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 17, 2020
Approval ID
ac3aab94453cb073
Type
Standard
Back to CIMA-AEMPS Approvals